BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19156579)

  • 1. Pathogenicity and growth characteristics of selected infectious laryngotracheitis virus strains from the United States.
    Oldoni I; Rodríguez-Avila A; Riblet SM; Zavala G; García M
    Avian Pathol; 2009 Feb; 38(1):47-53. PubMed ID: 19156579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of infectious laryngotracheitis virus (ILTV) isolates from commercial poultry by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP).
    Oldoni I; Rodríguez-Avila A; Riblet S; García M
    Avian Dis; 2008 Mar; 52(1):59-63. PubMed ID: 18459297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization by restriction fragment length polymorphism and sequence analysis of field and vaccine strains of infectious laryngotracheitis virus involved in severe outbreaks.
    Chacon JL; Mizuma MY; Piantino Ferreira AJ
    Avian Pathol; 2010 Dec; 39(6):425-33. PubMed ID: 21154050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of infectious laryngotracheitis virus isolates from the US by polymerase chain reaction and restriction fragment length polymorphism of multiple genome regions.
    Oldoni I; García M
    Avian Pathol; 2007 Apr; 36(2):167-76. PubMed ID: 17479379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States.
    Rodríguez-Avila A; Oldoni I; Riblet S; Garcia M
    Avian Pathol; 2008 Jun; 37(3):287-92. PubMed ID: 18568655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between mortality, clinical signs and tracheal pathology in infectious laryngotracheitis.
    Kirkpatrick NC; Mahmoudian A; Colson CA; Devlin JM; Noormohammadi AH
    Avian Pathol; 2006 Dec; 35(6):449-53. PubMed ID: 17121733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of infectious laryngotracheitis virus isolates: demonstration of viral subpopulations within vaccine preparations.
    García M; Riblet SM
    Avian Dis; 2001; 45(3):558-66. PubMed ID: 11569727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG; Kim SJ
    Avian Dis; 2003; 47(2):261-71. PubMed ID: 12887186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection and characterization from field cases of infectious laryngotracheitis virus by real-time polymerase chain reaction and restriction fragment length polymorphism.
    Creelan JL; Calvert VM; Graham DA; McCullough SJ
    Avian Pathol; 2006 Apr; 35(2):173-9. PubMed ID: 16595312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
    Perez-Contreras A; Barboza-Solis C; Najimudeen SM; Checkley S; Meer FV; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Ojkic D; Abdul-Careem MF
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of vaccine strains and Georgia field isolates of infectious laryngotracheitis virus by their restriction endonuclease fragment patterns.
    Andreasen JR; Glisson JR; Villegas P
    Avian Dis; 1990; 34(3):646-56. PubMed ID: 2173534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The route of inoculation dictates the replication patterns of the infectious laryngotracheitis virus (ILTV) pathogenic strain and chicken embryo origin (CEO) vaccine.
    Beltrán G; Williams SM; Zavala G; Guy JS; García M
    Avian Pathol; 2017 Dec; 46(6):585-593. PubMed ID: 28532159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage.
    Guy JS; Barnes HJ; Smith L
    Avian Dis; 1991; 35(2):348-55. PubMed ID: 1649591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the replication and transmissibility of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water.
    Coppo MJ; Devlin JM; Noormohammadi AH
    Avian Pathol; 2012; 41(1):99-106. PubMed ID: 22845327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In ovo vaccination of commercial broilers with a glycoprotein J gene-deleted strain of infectious laryngotracheitis virus.
    Mashchenko A; Riblet SM; Zavala G; García M
    Avian Dis; 2013 Jun; 57(2 Suppl):523-31. PubMed ID: 23901771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication and transmission of live attenuated infectious laryngotracheitis virus (ILTV) vaccines.
    Rodríguez-Avila A; Oldoni I; Riblet S; García M
    Avian Dis; 2007 Dec; 51(4):905-11. PubMed ID: 18251401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural infection of turkeys by infectious laryngotracheitis virus.
    Portz C; Beltrão N; Furian TQ; Júnior AB; Macagnan M; Griebeler J; Lima Rosa CA; Colodel EM; Driemeier D; Back A; Barth Schatzmayr OM; Canal CW
    Vet Microbiol; 2008 Sep; 131(1-2):57-64. PubMed ID: 18436397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of the tissue culture origin vaccine for infectious laryngotracheitis virus in commercial chicken flocks in Brazil.
    Parra SH; Nuñez LF; Astolfi-Ferreira CS; Ferreira AJ
    Poult Sci; 2015 Nov; 94(11):2608-15. PubMed ID: 26500264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.